Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Avnrt Mapping

Research Leaders

6 sponsors active, led by National Institute of Cardiology, Warsaw, Poland

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 4 (1)

Trial Status

Completed4
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT03376438Completed

Prospective Observational Cohort Study of Fetal Atrial Flutter & Supraventricular Tachycardia

NCT00618683Not ApplicableCompletedPrimary

AV Nodal Reentrant Tachycardia Study

NCT04764123UnknownPrimary

Typical and Atypical AVNRT High-resolution Mapping

NCT00621621Phase 4CompletedPrimary

CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)

NCT01594814CompletedPrimary

Patients' Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT

Showing all 5 trials

Research Network

Common Treatments

  • Avnrt Mapping1
  • Freezor Cardiac Cryoablation Catheter Cryoconsole System1
  • Cardiac Invasive Electrophysiological Study1
  • Rfa1
  • Prospective Observational Cohorts1

Active Sponsors

  • National Institute of Cardiology, Warsaw, Poland1
  • University of Oklahoma1
  • Johns Hopkins University1
  • Cardiovascular Research Society, Greece1
  • Edgar Jaeggi1

Top Investigators

Related Conditions

  • Tachycardia Atrial1
  • Reentrant Atrioventricular Tachycardia1
  • Tachycardia Supraventricular1
  • Tachycardia Atrial Ectopic1
  • Tachycardia Reciprocating1

Activity Timeline